Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
Product / operating segments
Reportable SegmentUSD 5.65B
Reported percentage. Percentages use consolidated company revenue unless a different denominator is stated.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
57
Fair
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
63
Fair
Financial Strength
64
Business Quality / Moat
58
Management
85
Growth Quality
28
Risk / Durability
76
Cheap for a Reason · Review the Risks
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
71
Fair
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
69/100
Building Historical Record
Model Score 69/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently rates the company as mixed to moderately strong.
At today’s price, the WSS valuation framework currently reads as relatively attractive.
The model outlook is currently moderate.
What we like
•Balance-sheet / debt profile scores strongly
•Valuation scores attractively
•Recent buyback activity is present
What to watch
•Revenue fundamentals are weak
•Asset quality is a weaker factor
Company-specific research
Questions worth answering for OPCH
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can OPCH maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is OPCH's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Is OPCH's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•Is OPCH's valuation discount tied to a temporary concern or to a longer-term business risk?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for OPCH
Detected from reported data — verify before acting.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on OPCH.
What the Bulls Say
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Product opportunity: Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions.
+Positive free cash flow may provide capacity to invest in growth.
What the Bears Say
−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Fair57/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Strong
72
Debt Cost5.0%
Debt Reduction YoY-4.5%
Debt / Equity0.96x
Tap for breakdown →
Revenue
Poor
37
Revenue YoY0.8%
Revenue CAGR14.6%
Net Margin3.7%
Tap for breakdown →
Asset
Poor
37
Asset Growth YoY1.0%
Liquidation/Share$7.71
Net Assets/MCap0.62x
Tap for breakdown →
Capital
Fair
64
Earnings Yield6.2%
Buyback Yield6.0%
Debt Cost5.0%
Tap for breakdown →
Management
Strong
85
ROIC10.6%
ROE16.6%
ROA6.2%
Tap for breakdown →
Moat
Fair
58
EPS Growth9.8%
FCF/Share Growth0.1%
Rev/Share Growth7.9%
Tap for breakdown →
Valuation
Elite
93
Intrinsic Value$45.14
Value Reference$27.08
MOS0.5%
Tap for breakdown →
Buffett
Fair
62
Revenue37
Moat58
Valuation93
Tap for breakdown →
MOS
Elite
100
MOS %0.5%
Value Reference$27.08
Deep Discount Reference$18.06
Tap for breakdown →
Financial
Poor
33
Interest Coverage5.3x
ROIC10.6%
FCF Yield6.4%
Tap for breakdown →
Master
Fair
51
Financial33
Valuation93
Debt72
Tap for breakdown →
Resilience
Fair
50
Survival Years0.5 yrs
Current Ratio1.53x
FCF Margin0.0%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
Score changes will appear once more historical records are available.